您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Gege Gui1,2, Molly A Bingham3, Julius R Herzog3
1Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.
使用 pembrolizumab 和 decitabine 的免疫疗法可能会增强急性髓性白血病 (AML) 中的免疫细胞相互作用. 这项研究揭示了白血病细胞附近的免疫细胞丰富,表明AML治疗中临床反应的潜在机制.
10:03Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
Published on: August 1, 2017
11:06Combining Intravital Fluorescent Microscopy IVFM with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: